Alcaro, S., Alteri, C., Artese, A., Ceccherini-Silberstein, F., Costa, G., Ortuso, F., et al. (2011). Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine. CHEMMEDCHEM, 6(12), 2203-2213 [10.1002/cmdc.201100362]. Dettagli
10.1002/cmdc.201100362
CitazioneAlcaro, S., Alteri, C., Artese, A., Ceccherini-Silberstein, F., Costa, G., Ortuso, F., et al. (2011). Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine. CHEMMEDCHEM, 6(12), 2203-2213 [10.1002/cmdc.201100362].Data2011-12-09idPUBBLICAZIONE_81007TipologiaArticolo su rivistaSSDSettore MED/07 - Microbiologia e Microbiologia ClinicaTutti gli AutoriDocking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and EtravirinetipologiaAlcaro, S; Alteri, C; Artese, A; Ceccherini-Silberstein, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, C; Sing, T; Svicher, V